SS Innovations International Inc. (NASDAQ: SSII) reported record first-quarter 2026 revenue of $11.1 million, a 116.8% increase compared to the same period last year, as the company continues to expand the global footprint of its SSi Mantra surgical robotic system. The company announced the results in a press release, highlighting strong growth in installations and procedure volumes.
Gross profit for the quarter rose to $5.3 million, up from $1.1 million a year earlier, reflecting improved operational leverage. The installed base of SSi Mantra systems reached 194 units across 11 countries, with nearly 9,750 cumulative robotic procedures completed as of the end of the first quarter. By June 22, 2026, that number had grown to 11,719 procedures, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, which has been used for over 170 different types of procedures.
The company is focusing on international expansion, having received regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines during the quarter. SS Innovations also recently completed the world’s longest-distance robotic cardiac telesurgery, demonstrating the capabilities of its remote surgery platform. The company continues to pursue regulatory clearance in both the United States and Europe while expanding its presence in emerging healthcare markets.
“Our record revenue reflects the accelerating adoption of the SSi Mantra system as more hospitals and surgeons recognize its potential to improve patient outcomes,” the company stated in its earnings announcement. The company’s financial performance underscores the growing demand for minimally invasive surgical robotics, particularly in regions where access to advanced healthcare technology is limited.
For more information, visit the company’s website at www.SSInnovations.com.
